Scientists are launching human trials for a cancer ‘vaccine’ that cured 97% of tumors in mice

Scientists at Stanford University are currently preparing for the first human test of what has been described as a cancer “vaccine,” a treatment which eliminated up to 97 percent of tumors during trials with mice. Appropriately 35 people with lymphoma will begin the trials before the end of 2018. Not technically a vaccine, the new cancer treatment is a kind of immunotherapy that involves an injection of two agents directly into a tumor. These agents then stimulate the production of T cells, which…